Customer Appreciation Sale.
15% off with promo code "APPRECIATION2023" on check out or purchase order
- Aaron Y. Lai, .et al. Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's disease., Brain, 2015, Apr;138(Pt 4):1046-58 PMID: 25688079
Biological Activity
Orantinib (TSU-68, SU6668) has greatest potency against PDGFR autophosphorylation with Ki of 8 nM in a cell-free assay, but also strongly inhibits Flk-1 and FGFR1 trans-phosphorylation, little activity against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2; does not inhibit EGFR. Phase 3.
Targets
PDGFRβ (Cell-free assay) | FGFR1 (Cell-free assay) | Flk1 (Cell-free assay) | ||
8 nM(Ki) | 1.2 μM(Ki) | 2.1 μM(Ki) |
In vitro (25°C) | DMSO | 55 mg/mL (177.22 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 1% DMSO+30% polyethylene glycol+1% Tween 80 | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 32.22 mL | 161.08 mL | 322.16 mL |
0.5 mM | 6.44 mL | 32.22 mL | 64.43 mL |
1 mM | 3.22 mL | 16.11 mL | 32.22 mL |
5 mM | 0.64 mL | 3.22 mL | 6.44 mL |
*The above data is based on the productmolecular weight 310.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A10953 |
---|---|
Actions | Inhibitor |
CAS No. | 252916-29-3 |
Formula | C18H18N2O3 |
M. Wt | 310.4 |
Purity | >98% |
Synonyms | TSU68 |
SMILES | CC1=C(NC(=C1CCC(=O)O)C)/C=C\2/C3=CC=CC=C3NC2=O |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Datasheet
Product Tags
Product Questions
Product Questions
No Questions
You may also be interested in the following product(s)
Vandetanib (ZD6474)
Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9…
Apatinib (YN968D1)
Apatinib (YN968D1) is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also …
Motesanib (AMG706)
Motesanib (AMG706) is a multikinase inhibitor that selectively targets VEGF receptors, platelet-derived growth factor receptors (PDGFRs), an…
Brivanib (BMS-540215)
Brivanib (BMS-540215) is a VEGFR -2 inhibitor with an IC50 of 25 nM and Ki of 26 nM.
BMS-690514
BMS-690514 is a potent and selective inhibitor of epidermal growth factor receptor (EGFR), HER2, and HER4, as well as the VEGF receptor kina…
E-3810
E-3810 is a potent and selective dual inhibitor of VEGF and FGF receptors with IC50 values of 7 nM, 25 nM, 10 nM, 17.5 nM and 82.5 nM for VE…
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. Regorafenib (BAY 73-4506) is an ora…
Raf265 derivative
Raf265 derivative is a derivative of Raf265 that is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 μM.
Keywords:buy TSU-68 (Orantinib, SU6668) | TSU-68 (Orantinib, SU6668) Supplier | purchase | cost | manufacturer | order | distributor | buy 252916-29-3| 252916-29-3 Supplier | purchase 252916-29-3 | 252916-29-3 cost | 252916-29-3 manufacturer | order 252916-29-3 | 252916-29-3 distributor